https://doi.org/10.5812/numonthly.2689

Insights into the Possible Mechanism of Cyclosporine-Induced Chronic Nephrotoxicity; Arteriolopathy

authors:

avatar Sang Yoon 1 , *

Department of Anatomy, School of Medicine, Jeju National University, Jeju-Do, Republic of Korea
Nephro-Urology Monthly: Vol.4, issue 2; 489-490
published online: March 1, 2012
article type: Letter
received: October 11, 2011
revised: October 19, 2011
accepted: October 23, 2011

how to cite: Yoon S. Insights into the Possible Mechanism of Cyclosporine-Induced Chronic Nephrotoxicity; Arteriolopathy. Nephro-Urol Mon. 2012;4(2): 489-490. https://doi.org/10.5812/numonthly.2689.

Dear Editor,

I read with great interest the recent contribution by Uz et al. (1) that demonstrated the protective effects of erdosteine on cyclosporine (CsA)-induced chronic nephrotoxicity in rats. The authors however, did not suggest the possible mechanism of nephrotoxicity or the recent reports concerning the action of antioxidants on nephrotoxicity. I would like to add some considerations on the noteworthy results using antioxidants based on the mechanism of CsA-induced chronic nephropathy.

Excessive free radical production has been attributed to inadequate renal perfusion and hypoxia-reoxygenation injury is a well-known prerequisite for chronic nephrotoxicity by the calcineurin inhibitor. CsA-induced chronic nephropathy is characterized not only by vasoconstriction but also by the development of irreversible structural damage including arteriolopathy and tubulointerstitial fibrosis (2). Although most patients do not exhibit nephropathy as a result of vasoconstrictive effects (3) which is the acute unequivocal consequence of CsA (4), arteriolopathy is thought to predispose patients to interstitial fibrosis with tubular atrophy. Therefore, arteriolar vasoconstriction is responsible for both hypertension and compromised glomerular filtration rates that invariably lead to chronic kidney disease over time.

Activation of the renin-angiotensin-aldosterone system (RAAS) plays an important role in the pathogenesis of chronic CsA-induced nephropathy. As highlighted in recent reports, it has been suggested that aldosterone plays a central role in the pathogenesis of CsA-induced nephrotoxicity (2). Ryu et al. (5) found that CsA treatment increases plasma renin activity and intrarenal renin levels, which induces nephrotoxicity, and that the protective effects of green tea extract on CsA-induced nephrotoxicity may block the RAAS. han et al. (6) revealed the effect of sirolimus on CsA and tacrolimus-induced nephrotoxicity using renal expression of the KloTho gene, which is an anti-aging gene. Defects in this gene are accompanied by arteriosclerosis, and it accelerates calcineurin inhibitor-induced nephrotoxicity by increased reactive oxygen species (ROS) production.

Two principle mechanisms of action have been proposed for antioxidants; one is a chain-breaking mechanism by electron donation (vitamin), and the other is the removal of RoS initiators by quenching chain initiating catalysts (erdosteine, green tea extract) (7). Besides, isoproterenol, which is a sympathomimetic, showed some protective effects by stimulating endogenous melatonin production in CsA-induced nephrotoxicity (8). Therefore, further studies are necessary to elucidate which molecular mechanisms are involved in the pathogenesis of CsAinduced nephropathy with special emphasis on arteriolopathy or the RAAS.

References

  • 1.

    Uz E, Uz B, Kaya A, Akdeniz D, Ruzgaresen NB, Uz E, et al. The protective effect of erdosteine on cyclosporine induced chronic nephrotoxicity in rats. Nephro-Urol Mon. 2012;3(4):280-4. https://doi.org/10.1152/ajprenal.00072.2007.

  • 2.

    Bobadilla NA, Gamba G. New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. Am J Physiol Renal Physiol. 2007;293(1):F2-9. [PubMed ID: 17429034]. https://doi.org/10.1152/ajprenal.00072.2007.

  • 3.

    Hesselink DA, Bouamar R, van Gelder T. The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity. Ther Drug Monit. 2010;32(4):387-93. [PubMed ID: 20571464]. https://doi.org/10.1097/FTD.0b013e3181e44244.

  • 4.

    Gaston RS. Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm. Clin J Am Soc Nephrol. 2009;4(12):2029-34. [PubMed ID: 19850771]. https://doi.org/10.2215/CJN.03820609.

  • 5.

    Ryu HH, Kim HL, Chung JH, Lee BR, Kim TH, Shin BC. Renoprotective effects of green tea extract on renin-angiotensin-aldosterone system in chronic cyclosporine-treated rats. Nephrol Dial Transplant. 2012;26(4):1188-93. [PubMed ID: 20947539]. https://doi.org/10.1093/ndt/gfq616.

  • 6.

    Han DH, Piao SG, Song JH, Ghee JY, Hwang HS, Choi BS, et al. Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. Transplantation. 2010;90(2):135-41.

  • 7.

    Rezzani R. Exploring cyclosporine A-side effects and the protective role-played by antioxidants: the morphological and immunohistochemical studies. Histol Histopathol. 2006;21(3):301-16. [PubMed ID: 16372251].

  • 8.

    Ghorbanihaghjo A, Argani H, Foroughimoghaddam H, Safa J, Rashtchizadeh N, Mesgari M. Effect of isoproterenol on cyclosporine-induced nephrotoxicity in rat. Transplant Proc. 2008;40(10):3737-41. [PubMed ID: 19100478]. https://doi.org/10.1016/j.transproceed.2008.06.055.